发明名称 経皮投与製剤
摘要 <p>Disclosed is an excellently safe transdermal preparation which enables excellent percutaneous absorption of citalopram, while having reduced skin irritation due to citalopram. Specifically disclosed is a transdermal preparation for reducing the skin irritation due to citalopram. The transdermal preparation contains at least one medicine selected from a group consisting of citalopram and pharmaceutically acceptable salts thereof, and at least one steroid selected from a group consisting of triamcinolone acetonide, flumethasone pivalate, alclometasone dipropionate, clobetasone butyrate, hydrocortisone butyrate, dexamethasone and prednisolone valerate acetate.</p>
申请公布号 JP5740300(B2) 申请公布日期 2015.06.24
申请号 JP20110501555 申请日期 2010.02.16
申请人 发明人
分类号 A61K31/343;A61K9/70;A61K31/573;A61K47/32;A61P17/00;A61P25/24;A61P43/00 主分类号 A61K31/343
代理机构 代理人
主权项
地址